| Issue |
Title |
File |
| Vol 23, No 12 (2023) |
New Approaches for the Synthesis N-alkylated Benzo[b]thiophene Derivatives together with their Antiproliferative and Molecular Docking Studies |
(Eng)
|
|
El-Sharkawy K., Mohamed A., Al Farouk F., Mohareb R.
|
| Vol 22, No 6 (2022) |
New C2- and N3-Modified Thieno[2,3-d]Pyrimidine Conjugates with Cytotoxicity in the Nanomolar Range |
(Eng)
|
|
Mavrova A., Dimov S., Yancheva D., Rangelov M., Wesselinova D., Naydenova E.
|
| Vol 14, No 5 (2014) |
New Drugs for Follicular Lymphoma in Older Adults |
(Eng)
|
|
Schmitt A., Soubeyran P.
|
| Vol 13, No 1 (2013) |
New Insight into P-Glycoprotein as a Drug Target |
(Eng)
|
|
Breier A., Gibalova L., Seres M., Barancik M., Sulova Z.
|
| Vol 10, No 3 (2010) |
New Medical Strategies for Midgut Carcinoids |
(Eng)
|
|
Nilsson O., Arvidsson Y., Johanson V., Forssell-Aronsson E., Ahlman H.
|
| Vol 14, No 9 (2014) |
New Perspective on the Dual Functions of Indirubins in Cancer Therapy and Neuroprotection |
(Eng)
|
|
Wang Y., Hoi P., Chan J., Lee S.
|
| Vol 14, No 9 (2014) |
New Potent and Selective Inhibitor of Pim-1/3 Protein Kinases Sensitizes Human Colon Carcinoma Cells to Doxorubicin |
(Eng)
|
|
Moreau P., Dezhenkova L., Anizon F., Nauton L., Thery V., Liang S., Kaluzhny D., Shtil A.
|
| Vol 12, No 1 (2012) |
New Targeted Therapies for Anaplastic Thyroid Cancer |
(Eng)
|
|
Antonelli A., Fallahi P., Ulisse S., Martina Ferrari S., Minuto M., Saraceno G., Santini F., Mazzi V., D'Armiento M., Miccoli P.
|
| Vol 15, No 4 (2015) |
New Treatments for Cutaneous Metastatic Melanoma: MAPK Pathway-Targeted and Immune Based Therapies |
(Eng)
|
|
Ranchon ., Boespflug ., Rioufol ., Schwiertz ., Thomas ., Dalle .
|
| Vol 23, No 10 (2023) |
New use of Old Drugs: Repurposing of Non-oncology Drugs for Cancer and Oncology Drugs for other Human Diseases |
(Eng)
|
|
Das V.
|
| Vol 23, No 10 (2023) |
Newly Synthesized Arylazo Derivatives Induce Apoptosis and G2/M Cell Cycle Arrest With Molecular Docking Validation in Human Cancer Cell Lines |
(Eng)
|
|
Laboud Y., Hassan N., Hassaneen H., Hassaneen H., Saleh F., Mohamed Teleb M.
|
| Vol 13, No 5 (2013) |
NF-κB Downregulation and PARP Cleavage by novel 3-α-butyryloxy-β-boswellic Acid Results in Cancer Cell Specific Apoptosis and in vivo Tumor Regression |
(Eng)
|
|
Qurishi Y., Hamid A., Sharma P.R., Wani Z.A., Mondhe D.M., Singh S.K., Zargar M.A., Andotra S.S., Shah B.A., Taneja S.C., Saxena A.K.
|
| Vol 15, No 3 (2015) |
NFκB Pathway and microRNA-9 and -21 are Involved in Sensitivity to the Pterocarpanquinone LQB-118 in Different CML Cell Lines |
(Eng)
|
|
de Faria F., Bento Leal M., Bernardo P., Costa P., Maia R.
|
| Vol 12, No 3 (2012) |
NGR-based Strategies for Targeting Delivery of Chemotherapeutics to Tumor Vasculature |
(Eng)
|
|
Zou M., Zhang L., Xie Y., Xu W.
|
| Vol 11, No 7 (2011) |
Nitroimidazoles as Anti-Tumor Agents |
(Eng)
|
|
Liu K., Zhu H.
|
| Vol 11, No 4 (2011) |
Nitroxides as Cancer Imaging Agents |
(Eng)
|
|
M. Davis R., B. Mitchell J., C. Krishna M.
|
| Vol 14, No 1 (2014) |
Nonsteroidal Aromatase Inhibitors for the Treatment of Breast Cancer: An Update |
(Eng)
|
|
Gobbi S., Rampa A., Belluti F., Bisi A.
|
| Vol 14, No 1 (2014) |
Nonsteroidal Aromatase Inhibitors for the Treatment of Breast Cancer: An Update |
(Eng)
|
|
Gobbi S., Rampa A., Belluti F., Bisi A.
|
| Vol 23, No 11 (2023) |
Novel 5-bromoindole-2-carboxylic Acid Derivatives as EGFR Inhibitors: Synthesis, Docking Study, and Structure Activity Relationship |
(Eng)
|
|
Hassan O., Kubba A., Tahtamouni L.
|
| Vol 14, No 7 (2014) |
Novel Action and Mechanism of Auranofin in Inhibition of Vascular Endothelial Growth Factor Receptor-3-Dependent Lymphangiogenesis |
(Eng)
|
|
Chen X., Zhou H., Huang Q., Lu L., Min W.
|
| Vol 24, No 3 (2024) |
Novel Anti-tumor Strategy for Breast Cancer: Synergistic Role of Oleuropein with Paclitaxel Therapeutic in MCF-7 Cells |
(Eng)
|
|
Yılmaz G., Özdemir F.
|
| Vol 23, No 14 (2023) |
Novel Arcyriaflavin-A Derivatives as PIM Kinase Inhibitors for Treating Cancer |
(Eng)
|
|
De S.
|
| Vol 25, No 1 (2025) |
Novel Celecoxib Derivative, RF26, Blocks Colon Cancer Cell Growth by Inhibiting PDE5, Activating cGMP/PKG Signaling, and Suppressing β-catenin-dependent Transcription |
(Eng)
|
|
Sigler S., Abdel-Halim M., Fathalla R., Da Silva L., Keeton A., Maxuitenko Y., Berry K., Zhou G., Engel M., Abadi A., Piazza G.
|
| Vol 14, No 6 (2014) |
Novel Mechanisms of Anticancer Activities of Green Tea Component Epigallocatechin- 3-Gallate |
(Eng)
|
|
Zhang L., Wei Y., Zhang J.
|
| Vol 13, No 9 (2013) |
Novel Molecular Anti- Colorectalcancer Conjugate:Chlorambucil-Adipic Acid Dihydrizide-Glutamine |
(Eng)
|
|
Tabasi M., Amanlou M., Siadat S., Nourmohammadi Z., Omoomi F., Sadat Ebrahimi S., Aghasadeghi M., Rahimi P., Pourhosseini S., Mehravi B., Ardestani M.
|
| Vol 24, No 7 (2024) |
Novel N-(3-ethynyl Phenyl)-6,7-bis(2-methoxyethoxy)Quinazoline-4-amine Derivatives: Synthesis, Characterization, Anti-cancer Activity, In-silico and DFT Studies |
(Eng)
|
|
Dash A., Vaddamanu G., Karreddula R., Manubolu S.S., G. P.K., Mulakayala N.
|
| Vol 24, No 14 (2024) |
Novel Piperazine Derivatives as Potent Antihistamine, Anti-Inflammatory, and Anticancer Agents, their Synthesis and Characterization |
(Eng)
|
|
Rasheed A., Shetty K., Roy L., Kumar J.
|
| Vol 25, No 4 (2025) |
Novel Quinoline Nitrate Derivatives: Synthesis, Characterization, and Evaluation of their Anticancer Activity with a Focus on Molecular Docking and NO Release |
(Eng)
|
|
Thanneeru V., Panigrahi N.
|
| Vol 15, No 8 (2015) |
Novel Series of Coumarinyl Substituted-thiazolidin-2,4-dione Analogs as Anticancer Agents: Design, Synthesis, Spectral Studies and Cytotoxicity Evaluation |
(Eng)
|
|
B. Palkar M., Jalalpure S.S., A. Rane R., M. Patel H., S. Shaikh M., A. Hampannavar G., S. Alwan W., S. Bolakatti G., Karpoormath R.
|
| Vol 12, No 7 (2012) |
Novel Strategies for Hepatocellular Carcinoma Based on MMPs Science |
(Eng)
|
|
Okazaki I., Inagaki Y.
|
| Vol 23, No 17 (2023) |
Novel Synthetic Indazoles Abrogate Angiogenesis in Erlich Ascites Tumor Bearing Mice |
(Eng)
|
|
Ashwini N., Balaji K., Sadashivaiah B., Swaroop T., Jayarama S., Mantelingu K., Rangappa K.
|
| Vol 10, No 2 (2010) |
Novel Therapeutic Agents Against Cancer Stem Cells of Chronic Myeloid Leukemia |
(Eng)
|
|
Chen Y., Peng C., Sullivan C., Li D., Li S.
|
| Vol 16, No 12 (2016) |
Novel Therapeutic Strategies Against Cancer: Marine-derived Drugs May Be the Answer? |
(Eng)
|
|
Gammone M., Riccioni G., Galvano F., D'Orazio N.
|
| Vol 10, No 2 (2010) |
Novel Therapies Against Aggressive and Recurrent Epithelial Cancers by Molecular Targeting Tumor- and Metastasis-Initiating Cells and Their Progenies |
(Eng)
|
|
Mimeault M., Batra S.
|
| Vol 15, No 1 (2015) |
Novel Triazolyl Berberine Derivatives Prepared via CuAAC Click Chemistry: Synthesis, Anticancer Activity and Structure-Activity Relationships |
(Eng)
|
|
Jin X., Yan L., Li H., Wang R., Hu Z., Jiang Y., Cao Y., Yan T., Sun Q.
|
| Vol 11, No 8 (2011) |
Nucleic Acid-Based Therapeutics for Glioblastoma |
(Eng)
|
|
Shir A., Levitzki A., Wagner E., Klein S., Ogris M.
|
| Vol 16, No 1 (2016) |
Nutrition, Nitrogen Requirements, Exercise and Chemotherapy-Induced Toxicity in Cancer Patients. A puzzle of Contrasting Truths? |
(Eng)
|
|
Flati V., Corsetti G., Pasini E., Rufo A., Romano C., Dioguardi F.
|
| Vol 10, No 6 (2010) |
Obesity Modulation - The Role in Carcinogenesis |
(Eng)
|
|
Legakis I., Syrigos K.
|
| Vol 25, No 8 (2025) |
Observation on the Therapeutic Efficacy of Camrelizumab Combined with Chemotherapy in Non-small Cell Lung Cancer and the Cutaneous Immune-related Adverse Events: A Retrospective Study |
(Eng)
|
|
Wang H., Xia J., Yu A., Cao M., Zhao Y., Qin X., Liu W., Han Z., Jiang G.
|
| Vol 16, No 11 (2016) |
Oleic Acid Protects Against Oxidative Stress Exacerbated by Cytarabine and Doxorubicin in Rat Brain |
(Eng)
|
|
Guzmán D., Brizuela N., Herrera M., Olguín H., García E., Peraza A., Mejía G.
|
| Vol 13, No 8 (2013) |
Omega-3 Polyunsaturated Fatty Acids and Cancer |
(Eng)
|
|
Jing K., Wu T., Lim K.
|
| Vol 13, No 7 (2013) |
Oncogenic MicroRNA-27a is a Target for Genistein in Ovarian Cancer Cells |
(Eng)
|
|
Xu L., Xiang J., Shen J., Zou X., Zhai S., Yin Y., Li P., Wang X., Sun Q.
|
| Vol 13, No 2 (2013) |
Oncogenic miR-544 is an Important Molecular Target in Gastric Cancer |
(Eng)
|
|
Zhi Q., Guo X., Guo L., Zhang R., Jiang J., Ji J., Zhang J., Zhang J., Chen X., Cai Q., Li j., Liu B., Zhu Z., Yu Y.
|
| Vol 13, No 9 (2013) |
Onco-Surgical Management of Colo-Rectal Liver Metastases in Older Patients: A New Frontier in the 3rd Millennium |
(Eng)
|
|
Benedetto F., D'Amico G., Spaggiari M., Tirelli U., Berretta M.
|
| Vol 12, No 5 (2012) |
Optical and Multimodal Peptide-Based Probes for In Vivo Molecular Imaging |
(Eng)
|
|
Melendez-Alafort L., Carlo Muzzio P., Rosato A.
|
| Vol 25, No 12 (2025) |
Optimized Rutin-incorporating PEGylated Nanoliposomes as a Model with Remarkable Selectivity Against PANC1 and MCF7 Cell Lines |
(Eng)
|
|
Al-Samydai A., Al Qaraleh M., Al-Halaseh L., Abu Hajleh M., Carradori S., Abdulmaged M., Kareem R., Alzaidi H., Mousa M., Al-Hiari Y., Nsairat H., Alshaer W.
|
| Vol 24, No 15 (2024) |
Optimizing Coreopsis tinctoria Flower Extraction and Inhibiting CML Activity: Box-Behnken Design |
(Eng)
|
|
Chen X., Zhou X., Gao Y.
|
| Vol 14, No 2 (2014) |
Orai1 and Transient Receptor Potential Channels as Novel Molecular Targets to Impair Tumor Neovascularization in Renal Cell Carcinoma and other Malignancies |
(Eng)
|
|
Moccia F., Dragoni S., Poletto V., Rosti V., Tanzi F., Ganini C., Porta C.
|
| Vol 14, No 5 (2014) |
Oral Chemotherapy in Elderly Women with Metastatic Breast Cancer |
(Eng)
|
|
Molina-Garrido M., Mora-Rufete A., Guillen-Ponce C.
|
| Vol 14, No 9 (2014) |
Organometallic Compounds in Cancer Therapy: Past Lessons and Future Directions |
(Eng)
|
|
Martins P., Marques M., Coito L., Pombeiro A., Baptista P., Fernandes A.
|
| Vol 25, No 11 (2025) |
Origanum syriacum Induces Apoptosis in Lung Cancer Cells by Altering the Ratio of Bax/Bcl2 |
(Eng)
|
|
Yumrutas O., Yumrutas P., Pehlivan M., Korkmaz M., Kahraman D.
|
| Vol 23, No 11 (2023) |
Osimertinib Induces the Opposite Effect of Proliferation and Migration in the Drug Resistance of EGFR-T790M Non-small Cell Lung Cancer Cells |
(Eng)
|
|
Wang R., Chang C., Chen C., Liu K., Chao J.
|
| Vol 24, No 2 (2024) |
Osmundacetone Inhibits Angiogenesis of Infantile Hemangiomas through Inducing Caspases and Reducing VEGFR2/MMP9 |
(Eng)
|
|
Ke C., Chen C., Yang M., Chen H., Li L., Ke Y.
|
| Vol 10, No 7 (2010) |
Overcoming Resistance of Glioblastoma to Conventional Cytotoxic Therapies by the Addition of PARP Inhibitors |
(Eng)
|
|
J. Chalmers A.
|
| Vol 14, No 8 (2014) |
Overcoming the Blood-Brain Barrier for Chemotherapy: Limitations, Challenges and Rising Problems |
(Eng)
|
|
Wang Z., Sun H., Yakisich J.
|
| Vol 24, No 16 (2024) |
Overexpression of NOP58 Facilitates Proliferation, Migration, Invasion, and Stemness of Non-small Cell Lung Cancer by Stabilizing hsa_circ_0001550 |
(Eng)
|
|
Jiang Y., Cai Y., Bao Y., Kong X., Jin H.
|
| Vol 15, No 1 (2015) |
Overview |
(Eng)
|
|
Prudhomme M.
|
| Vol 16, No 1 (2016) |
Overview |
(Eng)
|
|
Prudhomme M.
|
| Vol 24, No 4 (2024) |
Overview of the New Bioactive Heterocycles as Targeting Topoisomerase Inhibitors Useful Against Colon Cancer |
(Eng)
|
|
Santos M., de Azevedo Teotônio Cavalcanti M., de Medeiros e Silva Y.M., dos Santos Nascimento I., de Moura R.
|
| Vol 13, No 9 (2013) |
Oxaliplapin and Capecitabine (XELOX) Based Chemotherapy in the Treatment of Metastatic Colorectal Cancer: The Right Choice in Elderly Patients |
(Eng)
|
|
Berretta M., Aprile G., Nasti G., Urbani M., Bearz A., Lutrino S., Foltran L., Ferrari L., Talamini R., Fiorica F., Lleshi A., Canzonieri V., Lestuzzi C., Borsatti E., Fisichella R., Tirelli U.
|
| Vol 13, No 2 (2013) |
Oxaliplatin-induced Hyperexcitation of Rat Sciatic Nerve Fibers: An Intra-axonal Study |
(Eng)
|
|
Kagiava A., K. Kosmidis E., Theophilidis G.
|
| Vol 15, No 9 (2015) |
Ozone Dosage Effect on C6 Cell Growth: in Vitro and in Vivo Tests |
(Eng)
|
|
Pérez A., Santos Cuevas C., Chairez I., Poznyak T., Ordaz-Rosado D., García-Becerra R., Romero Piña M.
|
| Vol 15, No 2 (2015) |
p42.3: An Abductor of Cell Cycle |
(Eng)
|
|
Cao W., Mao L., Zheng J., Pei D.
|
| Vol 11, No 5 (2011) |
Pancreatic Cancer in Obesity: Epidemiology, Clinical Observations, and Basic Mechanisms |
(Eng)
|
|
J. Zyromski N., B. White P.
|
| Vol 15, No 10 (2015) |
Paraneoplastic Pemphigus: Autoimmune-Cancer Nexus in the Skin |
(Eng)
|
|
Sinha A.
|
| Vol 14, No 6 (2014) |
Paris polyphylla: Chemical and Biological Prospectives |
(Eng)
|
|
Negi J., Bisht V., Bhandari A., Bhatt V., Singh P., Singh N.
|
| Vol 23, No 13 (2023) |
p-Coumaric Acid Inhibits Osteosarcoma Growth by Inhibiting PI3K/Akt Signaling Pathway |
(Eng)
|
|
Yang B., Wang B., Wang G., Cao W., Wang Q., Pu H., An W.
|
| Vol 25, No 4 (2025) |
PEGylated Titanium Dioxide Nanoparticle-bound Doxorubicin and Paclitaxel Drugs Affect Prostate Cancer Cells and Alter the Expression of DUSP Family Genes |
(Eng)
|
|
Tuncbilek Z., Cakmak N., Tas A., Ayan D., Silig Y.
|
| Vol 12, No 5 (2012) |
Peptide Receptor Radionuclide Therapy with Somatostatin Analogues in Neuroendocrine Tumors |
(Eng)
|
|
Giovacchini G., Nicolas G., Forrer F.
|
| Vol 12, No 5 (2012) |
Peptide-Receptor Ligands and Multivalent Approach |
(Eng)
|
|
Ruzza P., Marchiani A., Antolini N., Calderan A.
|
| Vol 16, No 12 (2016) |
Peroxisome Proliferator-Activated Receptors and their Ligands in Cancer Drug- Resistance: Opportunity or Challenge |
(Eng)
|
|
Yousefi B., Zarghami N., Samadi N., Majidinia M.
|
| Vol 10, No 4 (2010) |
Perspectives for Novel Mixed Diruthenium-Organic Drugs as Metallopharmaceuticals in Cancer Therapy |
(Eng)
|
|
de Oliveira Silva D.
|
| Vol 16, No 11 (2016) |
Perspectives of Benzimidazole Derivatives as Anticancer Agents in the New Era |
(Eng)
|
|
Yadav S., Narasimhan B., kaur H.
|
| Vol 10, No 8 (2010) |
Pharmacogenetics of Drug Metabolizing Enzymes and Transporters: Effects on Pharmacokinetics and Pharmacodynamics of Anticancer Agents |
(Eng)
|
|
H. Lee N.
|
| Vol 10, No 8 (2010) |
Pharmacogenomics of Human ABC Transporter ABCC11 (MRP8): Potential Risk of Breast Cancer and Chemotherapy Failure |
(Eng)
|
|
Toyoda Y., Ishikawa T.
|
| Vol 12, No 2 (2012) |
Pharmacologic Inhibition of mTOR Improves Lapatinib Sensitivity in HER2-Overexpressing Breast Cancer Cells with Primary Trastuzumab Resistance |
(Eng)
|
|
S. Gayle S., L.M. Arnold S., M. O'Regan R., Nahta R.
|
| Vol 24, No 17 (2024) |
PHD-BAH Domain in ASH1L Could Recognize H3K4 Methylation and Regulate the Malignant Behavior of Cholangiocarcinoma |
(Eng)
|
|
Zhang X., Li Y.
|
| Vol 11, No 10 (2011) |
Phosphine-Gold(I) Compounds as Anticancer Agents: General Description and Mechanisms of Action |
(Eng)
|
|
Carlos Lima J., Rodriguez L.
|
| Vol 14, No 5 (2014) |
Physiological Modulation Approaches to Improve Cancer Chemotherapy : A Review |
(Eng)
|
|
Kumar R., Kaur M., Silakari O.
|
| Vol 14, No 3 (2014) |
Phytochemical and Biological Activities of an Anticancer Plant Medicine: Brucea javanica |
(Eng)
|
|
Zhao L., Li C., Zhang Y., Wen Q., Ren D.
|
| Vol 23, No 11 (2023) |
Phytochemicals in the Synthetic Era: A Potential Oncosuppressor against Cancer Stem Cells |
(Eng)
|
|
Maru D., Kumar A.
|
| Vol 24, No 10 (2024) |
Phytol and α-Bisabolol Synergy Induces Autophagy and Apoptosis in A549 Cells and Additional Molecular Insights through Comprehensive Proteome Analysis via Nano LC-MS/MS |
(Eng)
|
|
Kiruthiga C., Niharika K., Devi K.
|
| Vol 25, No 7 (2025) |
Pioneering a New Era in Oral Cancer Treatment with Electrospun Nanofibers: A Comprehensive Insight |
(Eng)
|
|
Tripathi D., Gupta T., Rai A., Pandey P.
|
| Vol 25, No 3 (2025) |
Pioneering the Battle Against Breast Cancer: The Promise of New Bcl-2 Family |
(Eng)
|
|
Boroujeni A., Ates-Alagoz Z.
|
| Vol 24, No 16 (2024) |
Pistacia vera and its Combination with Cisplatin: A Potential Anticancer Candidate by Modulating Apoptotic Genes |
(Eng)
|
|
Khanamani Falahati-Pour S., Torabizadeh S., Baghery F., Noroozi-Karimabad M.
|
| Vol 14, No 10 (2014) |
Plant Coumestans: Recent Advances and Future Perspectives in Cancer Therapy |
(Eng)
|
|
Nehybova T., Smarda J., Benes P.
|
| Vol 12, No 10 (2012) |
Plants vs. Cancer: A Review on Natural Phytochemicals in Preventing and Treating Cancers and Their Druggability |
(Eng)
|
|
Wang H., Oo Khor T., Shu L., Su Z., Fuentes F., Lee J., Tony Kong A.
|
| Vol 13, No 2 (2013) |
Platinum Compounds: A Hope for Future Cancer Chemotherapy |
(Eng)
|
|
Ali I., A. Wani W., Saleem K., Haque A.
|
| Vol 11, No 6 (2011) |
Points of Therapeutic Intervention Along the Wnt Signaling Pathway in Hepatocellular Carcinoma |
(Eng)
|
|
B. Nambotin S., R. Wands J., Kim M.
|
| Vol 15, No 2 (2015) |
Poly(Ethylene Glycol) Amphiphilic Copolymer for Anticancer Drugs Delivery |
(Eng)
|
|
Feng R., Zhu W., Teng F., Liu N., Yang F., Meng N., Song Z.
|
| Vol 12, No 8 (2012) |
Polyphenols Counteract Tumor Cell Chemoresistance Conferred by Multidrug Resistance Proteins |
(Eng)
|
|
Michalak K., Wesolowska O.
|
| Vol 10, No 8 (2010) |
Pomegranate Extract, A Prooxidant with Antiproliferative and Proapoptotic Activities Preferentially Towards Carcinoma Cells |
(Eng)
|
|
H. Weisburg J., G. Schuck A., S. Silverman M., G. Ovits-Levy C., J. Solodokin L., L. Zuckerbraun H., Babich H.
|
| Vol 13, No 8 (2013) |
Pomegranate Extracts and Cancer Prevention: Molecular and Cellular Activities |
(Eng)
|
|
Syed D., Chamcheu J., Adhami V., Mukhtar H.
|
| Vol 21, No 2 (2021) |
Possible Enhancement of Photodynamic Therapy (PDT) Colorectal Cancer Treatment when Combined with Cannabidiol |
(Eng)
|
|
Nkune N., Kruger C., Abrahamse H.
|
| Vol 15, No 1 (2015) |
Potential Anticancer Agents. I. Synthesis of Isoxazole Moiety Containing Quinazoline Derivatives and Preliminarily in vitro Anticancer Activity |
(Eng)
|
|
Yong J., Lu C., Wu X.
|
| Vol 12, No 2 (2012) |
Potential Anticancer Properties of Bisphosphonates: Insights From Preclinical Studies |
(Eng)
|
|
Clezardin P.
|
| Vol 16, No 1 (2016) |
Potential Molecular Targeted Therapeutics: Role of PI3-K/Akt/mTOR Inhibition in Cancer |
(Eng)
|
|
Sokolowski K., Koprowski S., Kunnimalaiyaan S., Balamurugan M., Gamblin T., Kunnimalaiyaan M.
|
| Vol 10, No 9 (2010) |
Potential New Agents for Chronic Lymphocytic Leukemia Treatment |
(Eng)
|
|
Rogalinska M., M. Kilianska Z.
|
| Vol 24, No 7 (2024) |
Potential of Nanomedicines as an Alternative for the Treatment of Colorectal Cancer - A Review |
(Eng)
|
|
Nicolau Costa K., Barros L.A., da Silva Soares I.L., Oshiro-Junior J.A.
|
| Vol 10, No 2 (2010) |
Potential Targets for Improving Radiosensitivity of Breast Tumor-Initiating Cells |
(Eng)
|
|
Xu W., Debeb B., Lacerd L., Woodward W.
|
| 801 - 900 of 1242 Items |
<< < 1 2 3 4 5 6 7 8 9 10 11 12 13 > >> |
